Pharmacokinetics and pharmacodynamics of canagliflozin in pediatric patients with type 2 diabetes.

about

Pharmacokinetics and pharmacodynamics of canagliflozin in pediatric patients with type 2 diabetes.

Item

http://www.wikidata.org/entity/Q47260852

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Pharmacokinetics and pharmacod ...... patients with type 2 diabetes.

@en

Pharmacokinetics and pharmacod ...... patients with type 2 diabetes.

@nl

type

Item

label

Pharmacokinetics and pharmacod ...... patients with type 2 diabetes.

@en

Pharmacokinetics and pharmacod ...... patients with type 2 diabetes.

@nl

prefLabel

Pharmacokinetics and pharmacod ...... patients with type 2 diabetes.

@en

Pharmacokinetics and pharmacod ...... patients with type 2 diabetes.

@nl

P1476

Pharmacokinetics and pharmacod ...... patients with type 2 diabetes.

@en

P2093

David Polidori

http://www.w3.org/2001/XMLSchema#string

Domenick Argenti

http://www.w3.org/2001/XMLSchema#string

Nicholas A Di Prospero

http://www.w3.org/2001/XMLSchema#string

P2860

A cross-sectional view of the current state of treatment of youth with type 2 diabetes in the USA: enrollment data from the Pediatric Diabetes Consortium Type 2 Diabetes Registry.

Pharmacodynamic effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, from a randomized study in patients with type 2 diabetes.

Dose-ranging effects of canagliflozin, a sodium-glucose cotransporter 2 inhibitor, as add-on to metformin in subjects with type 2 diabetes.

Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes on background metformin and pioglitazone.

Efficacy and safety of canagliflozin monotherapy in subjects with type 2 diabetes mellitus inadequately controlled with diet and exercise.

Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin and sulphonylurea: a randomised trial

Youth-onset type 2 diabetes mellitus: lessons learned from the TODAY study.

Metformin monotherapy in youth with recent onset type 2 diabetes: experience from the prerandomization run-in phase of the TODAY study

A clinical trial to maintain glycemic control in youth with type 2 diabetes.

Expanding Treatment Options for Youth With Type 2 Diabetes: Current Problems and Proposed Solutions: A White Paper From the NICHD Diabetes Working Group

P31

scholarly article

P356

10.1111/PEDI.12626

http://www.w3.org/2001/XMLSchema#string

P50

William V Tamborlane

P577

2017-12-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29271103

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes